반응 #1702130

ord-ada7f289380348e0bb86b47e9f3075a9

반응 방정식

Cl
HCl
Oc1cccc(CCNc2nc(Nc3cccc(CBr)c3)ncc2Cl)c1
3-{2-[(2-{[3-(bromomethyl)phenyl]amino}-5-chloropyrimidin-4-yl)amino]ethyl}phenol
[Na+].[OH-]
sodium hydroxide
Clc1cnc2nc1NCCc1cccc(c1)OCc1cccc(c1)N2
desired product
수율 65.0%
Clc1cnc2nc1NCCc1cccc(c1)OCc1cccc(c1)N2
19-Chloro-9-oxa-2,17,21,22-tetraazatetracyclo[16.3.1.1(3,7).1(10,14)]tetracosa-1(22),3(24),4,6,10(23),11,13,18,20-nonaene
수율 65.0%

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    추출The aqueous layer was extracted with EtOAc twice
  2. 2
    건조The combined organic layers were dried over Na2SO4
  3. 3
    여과filtered
  4. 4
    농축concentrated (
  5. 5
    기타then triturated with cold EtOAc)

실험 절차

To a solution of 3-{2-[(2-{[3-(bromomethyl)phenyl]amino}-5-chloropyrimidin-4-yl)amino]ethyl}phenol (25.0 mg, 0.0576 mmol) in tetrahydrofuran (0.561 mL) was added a solution of sodium hydroxide in water (0.46 mL, 0.50 M). The resultant solution was stirred at rt for 16 hours until the reaction was complete. The reaction mixture was neutralized with aqueous HCl solution (3 M) to pH 7. The aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over Na2SO4, filtered, and concentrated (then triturated with cold EtOAc) to give the desired product as an off-white powder (13 mg, 65%). LCMS for C19H18ClN4O (M+H)+: m/z=353.0. 1H NMR (400 MHz, CD3OD): δ 7.72 (s, 1H), 7.52 (s, 1H), 7.29 (t, J=7.6 Hz, 1H), 7.19 (s, 1H), 7.10 (dd, J=7.6, 0.8 Hz, 1H), 7.06 (t, J=7.2 Hz, 1H), 6.93 (dd, J=7.2, 0.8 Hz, 1H), 6.73 (dd, J=2.4, 0.8 Hz, 1H), 6.66 (d, J=7.2 Hz, 1H), 5.25 (s, 2H), 3.70 (m, 2H), 2.72 (t, J=6.8 Hz, 1H).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08765727B2uspto-grants-2014_07